MARKET

YCBD

YCBD

cbdMD Inc
AMEX

Real-time Quotes | Nasdaq Last Sale

1.040
-0.020
-1.89%
After Hours: 1.050 +0.01 +0.96% 18:12 01/24 EST
OPEN
1.040
PREV CLOSE
1.060
HIGH
1.053
LOW
0.9700
VOLUME
428.10K
TURNOVER
--
52 WEEK HIGH
6.83
52 WEEK LOW
0.9700
MARKET CAP
60.12M
P/E (TTM)
-2.1377
1D
5D
1M
3M
1Y
5Y
Cannabis Stock Gainers And Losers From January 18, 2022
GAINERS: Item 9 Labs (OTC:INLB) shares closed up 11.46% at $1.07
Benzinga · 6d ago
Cannabis Stock Gainers And Losers From December 30, 2021
GAINERS: Urban-gro (NASDAQ:UGRO) % shares closed up 7.97% at $10.16
Benzinga · 12/30/2021 21:42
cbdMD Reports 6% YoY Increase To Record $44.5M In Net Sales In 2021
cbdMD, Inc. (NYSE: YCBD) announced its financial results on Friday for the fourth quarter and fiscal year ended September 30. Based in Charlotte, North Carolina, the company's net sales hit a record of $44.5 million in fiscal 2021.
Benzinga · 12/20/2021 17:33
cbdMD's Return On Capital Employed Insights
Benzinga Pro data, cbdMD (AMEX:YCBD) reported Q4 sales of $9.79 million. Earnings fell to a loss of $3.03 million, resulting in a 296.85% decrease from last quarter. In Q3, cbdMD earned $1.54 million and total sales reached $10.56 million.
Benzinga · 12/20/2021 14:48
25 Stocks Moving in Monday's Pre-Market Session
Gainers Society Pass Incorporated (NASDAQ: SOPA) rose 68% to $5.59 in pre-market trading after the company reported addition to the Russell 2000 Index.
Benzinga · 12/20/2021 11:35
BRIEF-cbdMD Inc Reports FY Loss Per Share $0.47
reuters.com · 12/17/2021 22:35
cbdMD: Q4 Earnings Insights
cbdMD (AMEX:YCBD) reported its Q4 earnings results on Friday, December 17, 2021 at 04:10 PM. Here's what investors need to know about the announcement. Earnings cbdMD reported in-line EPS of $-0.04 versus an estimate of $-0.04, which did not surprise analy...
Benzinga · 12/17/2021 21:35
cbdMD EPS misses by $0.10, misses on revenue
cbdMD (NYSE:YCBD): FY GAAP EPS of -$0.47 misses by $0.10. Revenue of $44.48M (+6.2% Y/Y) misses by $1.46M. Shares -8.27%. Press Release Adjusted gross margin totaled 19.6% for fiscal 2021,
Seekingalpha · 12/17/2021 21:35
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of YCBD. Analyze the recent business situations of cbdMD Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

0.00%Strong Buy
50.00%Buy
50.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average YCBD stock price target is 5.13 with a high estimate of 8.00 and a low estimate of 2.400.
High8.00
Average5.13
Low2.400
Current 1.040
EPS
Actual
Estimate
-0.19-0.14-0.10-0.05
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Institutional Holdings
Institutions: 37
Institutional Holdings: 2.71M
% Owned: 4.70%
Shares Outstanding: 57.81M
TypeInstitutionsShares
Increased
9
794.82K
New
25
1.06M
Decreased
1
42.37K
Sold Out
5
88.17K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
-1.15%
Pharmaceuticals & Medical Research
-0.55%
Key Executives
Chairman/Co-Chief Executive Officer/Director
Martin Sumichrast
Co-Chief Executive Officer/Director
Raymond Coffman
Chief Financial Officer
T. Ronan Kennedy
Senior Vice President
Francisco Mangual
Chief Marketing Officer
Ken Cohn
General Counsel
Lance Blundell
Director/IR Contact Officer
John Weston
Independent Director
Peter Ghiloni
Independent Director
William Raines
Independent Director
Bakari Sellers
Independent Director
Scott Stephen
No Data
About YCBD
cbdMD, Inc. owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD and cbdMD Botanicals. The Company’s cbdMD brand products categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD bath bombs, CBD bath salts and CBD sleep aids. The Paw CBD brand of products includes tinctures, chews and topicals. Its cbdMD Botanicals includes facial oil and serum, toners, moisturizers, clear skin, facial masks, exfoliants and body care.

Webull offers kinds of cbdMD Inc stock information, including AMEX:YCBD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, YCBD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading YCBD stock methods without spending real money on the virtual paper trading platform.